Merck & Co and Japan’s Eisai have reached a deal to develop and sell two of their cancer drugs, which are already approved as separately and in combination therapies, in a deal that could ...

The global Tissue Diagnostic Market is valued at USD 8.81 billion in 2024 and is projected to reach a value of USD 19.01 ...

The Global Mycoplasma Testing Market is expected to witness a high growth rate of 11% from 2022 to 2027. Growing R&D ...

The real-world evidence solutions market is largely driven by the increasing prevalence of chronic diseases and their impact on real-world healthcare ...

The Demarie Insurance transaction is the latest in a string of strategic moves by HUB Gulf South since Norris became president in 2019. During the past five years, HUB has purchased a total of 18 ...

Trace3 President Joe Quaglia told CRN that Seattle-based Ivoxy brings his company an expanded geographic presence in a key market for Trace3, ranked No. 34 in the CRN 2025 Solution Provider 500 ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

The company supplies methanol to petrochemical producers and distributors through its marketing offices in North America (Vancouver and Dallas), Europe (Brussels), Asia Pacific (Hong Kong ...

Sanofi’s SNY stock has been trading below its 200-day and 50-day moving averages since early June. On June 23, the stock’s ...

The global Isooctyl Alcohol market is set to achieve a significant milestone by reaching a valuation of USD 723.6 million by ...